eg-0224
From
v29.4
JSON-LD
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalGuidelineRecommendation",
"evidenceLevel": "https://schema.org/EvidenceLevelA",
"evidenceOrigin": "multiple randomized clinical trials",
"recommendationStrength": "Strong recommendation",
"guidelineSubject": [
{
"@type": "Drug",
"name": "NewvoDrug"
},
{
"@type": "MedicalCondition",
"name": "cardiac failure"
}
]
},
{
"@type": "MedicalGuidelineContraindication",
"evidenceLevel": "https://schema.org/EvidenceLevelC",
"evidenceOrigin": "standard of care",
"guidelineSubject": [
{
"@type": "MedicalCondition",
"name": "cardiac failure"
},
{
"@type": "TherapeuticProcedure",
"name": "appendectomy"
}
]
}
]
}RDFa
<h1>Guidelines</h1>
<ul>
<li>Recommendation:
<span typeof="MedicalGuidelineRecommendation">
<span property="guidelineSubject" typeof="Drug">
<span property="name">NewvoDrug</span>
</span>
is indicated for initial treatment of
<span property="guidelineSubject" typeof="MedicalCondition">
<span property="name">cardiac failure</span>
</span>
for all adult patients.
(<span property="recommendationStrength">Strong recommendation</span>;
<a property="evidenceLevel" href="https://schema.org/EvidenceLevelA">
Class I</a>,
based on
<span property="evidenceOrigin">multiple randomized clinical trials</span>)
</span>
</li>
<li>Contraindication:
<span typeof="MedicalGuidelineContraindication">
<span property="guidelineSubject" typeof="MedicalCondition">
<span property="name">cardiac failure</span></span> should never
be treated with
<span property="guidelineSubject" typeof="TherapeuticProcedure">
<span property="name">appendectomy</span></span> in adults.
(Class III, <link property="evidenceLevel" href="https://schema.org/EvidenceLevelC"/>
<span property="evidenceOrigin">standard of care</span>)
</span></li>
</ul>Microdata
<h1>Guidelines</h1>
<ul>
<li>Recommendation:
<span itemscope itemtype="https://schema.org/MedicalGuidelineRecommendation">
<span itemprop="guidelineSubject" itemscope itemtype="https://schema.org/Drug">
<span itemprop="name">NewvoDrug</span>
</span>
is indicated for initial treatment of
<span itemprop="guidelineSubject" itemscope itemtype="https://schema.org/MedicalCondition">
<span itemprop="name">cardiac failure</span>
</span>
for all adult patients.
(<span itemprop="recommendationStrength">Strong recommendation</span>;
<a itemprop="evidenceLevel" href="https://schema.org/EvidenceLevelA">Class I</a>,
based on
<span itemprop="evidenceOrigin">multiple randomized clinical trials</span>)
</span>
</li>
<li>Contraindication:
<span itemscope itemtype="https://schema.org/MedicalGuidelineContraindication">
<span itemprop="guidelineSubject" itemscope itemtype="https://schema.org/MedicalCondition">
<span itemprop="name">cardiac failure</span></span> should never
be treated with
<span itemprop="guidelineSubject" itemscope itemtype="https://schema.org/TherapeuticProcedure">
<span itemprop="name">appendectomy</span></span> in adults.
(Class III, <link itemprop="evidenceLevel" href="https://schema.org/EvidenceLevelC"/>
<span itemprop="evidenceOrigin">standard of care</span>)
</span></li>
</ul>Pre-Markup
<h1>Guidelines</h1> <ul> <li>Recommendation: NewvoDrug is indicated for initial treatment of cardiac failure for all adult patients. (Strong recommendation; Class I, based on multiple randomized clinical trials)</li> <li>Contraindication: cardiac failure should never be treated with appendectomy in adults. (Class III, standard of care)</li> </ul>